Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Every Step You Take: Tracking Patients Using Wearable Technology
-
- ACR Renews Warning Against Step Therapy for Part B Drugs
- Closing the Gap Between Patients and Rheumatology Providers: A New Problem? Leonard H. Calabrese, DO
- FDA panel: Febuxostat Benefits Outweigh CV Risks, but Reduce Use
- Amid New Year Drug Price Hikes, Congress Calls on Manufacturers to Justify Costs
- Bone Erosions Detected in 44% of Patients With Gout
- Cardiovascular Comorbidity Burden Similar in RA, Systemic Sclerosis
- Direct-to-consumer Medical Ad Spending Rises $7.5 Billion Over 10 Years
- IgA Vasculitis Linked to Higher Risk for Hypertension, Chronic Kidney Disease
-
- Long-term Effectiveness of Pain Medications Uncertain in Knee OA
- Pegloticase Effective for Rapid Resolution of Tophi in Gout
- Single-infusion Rituximab Slows RA Development in At-risk Patients
- ACR: New Medicare International Pricing Index Should be Voluntary
- Infection Risk With Abatacept Lower Than TNF Inhibitors in RA
- Opioid Use Doubled in Patients With RA From 2002 to 2015
- Price Hikes on Older, Brand-name Drugs Share Blame for Surging Drug Costs
- SLE Linked to Increased Risk for 16 Cancers, Decreased Risk for Melanoma
-